Skip to main content
DermTech, Inc. (DMTK)
NASDAQ: DMTK · IEX Real-Time Price · USD
0.603
+0.018 (3.02%)
At close: Apr 26, 2024, 4:00 PM
0.635
+0.032 (5.29%)
After-hours: Apr 26, 2024, 7:54 PM EDT

DermTech Revenue

In the year 2023, DermTech had annual revenue of $15.30M with 5.36% growth. Revenue in the quarter ending December 31, 2023 was $3.92M with 31.06% year-over-year growth.

Revenue (ttm)
$15.30M
Revenue Growth
+5.36%
P/S Ratio
1.37
Revenue / Employee
$74,252
Employees
206
Market Cap
20.88M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202315.30M778.00K5.36%
Dec 31, 202214.52M2.68M22.64%
Dec 31, 202111.84M5.95M101.16%
Dec 31, 20205.89M2.52M74.94%
Dec 31, 20193.36M922.00K37.76%
Dec 31, 20182.44M--
Mar 31, 20170--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
MEI Pharma 72.65M
American Shared Hospital Services 21.33M
Accelerate Diagnostics 12.06M
NeurAxis 2.46M
OncoCyte 1.50M
AIM ImmunoTech 202.00K
Alaunos Therapeutics 5.00K
Revenue Rankings

DMTK News

More News